# Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

> **NCT05619562** · — · COMPLETED · sponsor: **The Institute of Molecular and Translational Medicine, Czech Republic** · enrollment: 166 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Circulating Tumor Cell

## Interventions

- **DIAGNOSTIC_TEST:** Device for CTC/DTC detection

## Key facts

- **NCT ID:** NCT05619562
- **Lead sponsor:** The Institute of Molecular and Translational Medicine, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-04
- **Final completion:** 2015-12
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05619562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05619562, "Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05619562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*